• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Teva Pharmaceuticals

AZ
Pharma

AstraZeneca returns to industry association PhRMA

Two years after leaving the Pharmaceutical Research and Manufacturers of America, AstraZeneca has rejoined the industry trade group.
Kevin Dunleavy Apr 22, 2025 4:34pm
Viatris

Viatris settles opioid claims, agreeing to pay up to $335M

Apr 7, 2025 10:48am
Red and blue boxing gloves on a black background

Powerhouse companies back Teva lawsuit against IRA drug pricing

Mar 18, 2025 11:36am
Judge banging gavel on stack of money

Gilead sets aside $200M for potential settlement with government

Mar 4, 2025 11:32am
A closeup of a stock market ticker

Of 22 top drugmakers, 21 delivered revenue increases in Q4

Feb 24, 2025 10:27am
settlement

Teva agrees with Axsome to keep generic off market until 2038

Feb 10, 2025 11:28am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings